Literature DB >> 6094005

Tamoxifen and conjugated estrogens (Premarin) followed by sequenced methotrexate and 5-FU in refractory advanced breast cancer.

E A Eisenhauer, D M Bowman, K I Pritchard, A H Paterson, J Ragaz, I Plenderleith, P H Geggie, I Maxwell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6094005

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  3 in total

1.  Elevated plasma tamoxifen levels in a patient with liver obstruction.

Authors:  M W DeGregorio; V J Wiebe; A P Venook; W M Holleran
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 2.  Tamoxifen. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.

Authors:  M M Buckley; K L Goa
Journal:  Drugs       Date:  1989-04       Impact factor: 9.546

3.  Characterisation of VP-16-induced DNA cleavage in oestrogen-stimulated human breast cancer cells.

Authors:  R J Epstein; P J Smith; J V Watson; N M Bleehen
Journal:  Br J Cancer       Date:  1988-05       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.